is class speaker! Katja Bezjak SLOVENIA Bezjak.Katja @ mh-hannover.de Supervisor: Prof. Dr. Thilo Dörk-Bousset (Molecular Gynaecoloy) Left the program in spring 2022 due to personal reasons! Büsra Cinar

June 2019. Dhanya Ramachandran INDIA Ramachandran.Dhanya@mh-hannover.de Supervisor: Prof. Dr. Thilo Dörk-Bousset, OE 6411, Project: Identification and functional characterization of novel cervical cancer

Studien | Hebammenwissenschaft Forschungszentrum in der Frauenklinik Dr. T. Dörk-Bousset Tel.: +49 511 532 6075 @ doerk.thilo @ mh-hannover.de Hebammenwissenschaft Fr. Prof. Dr. phil. M. Groß, Hebamme Tel

implicated in cardiomyopathy. Final exam November 2021. Anna Vatselia GREECE Supervisor:Prof. Dr. Thilo Dörk-Bousset, Department of Gynarécology, OE 6411, Project: Functional characterization of a mitotic RAD50

Third-Generation Anti-CD24-CAR against Ovarian Cancer Rüdiger Klapdor, Shuo Wang, Michael Morgan, Thilo Dörk, Ulrich Hacker, Peter Hillemanns, Hildegard Büning and Axel Schambach Int. J. Mol. Sci. 2019, 20 [...] Receptor Directed against CD44. Klapdor R, Wang S, Morgan MA, Zimmermann K, Hachenberg J, Büning H, Dörk T, Hillemanns P, Schambach A. Biomedicines 2021;9(10):1339 DOI: 10.3390/biomedicines9101339 Prognostic [...] novel CAR-based immunotherapy and chemotherapy. Klapdor R, Wang S, Hacker U, Büning H, Morgan M, Dörk-Bousset T, Hillemanns P, Schambach A. Hum Gene Ther 2017;28(10):886-896 Optimization of Human NK Cell

Girmay Asgedom, Holger Bastians, Martin Lavin, Detlev Schindler, Axel Schambach, Kristine Bousset, Thilo Dörk FASEB J. 2020 Feb;34(2):2812-2820.doi: 10.1096/fj.201902318R. Epub 2019 Dec 31. Cooperating

Forschung | Lehre | Studien Gesamtüberblick über Aktivitäten in Forschung, Lehre und Studien aus allen Fachbereichen der Klinik für Frauenheilkunde und Geburtshilfe.